Celon Pharma S.A. (WSE:CLN)
Poland · Delayed Price · Currency is PLN 19.64
-0.14 (-0.71%)
Jul 6, 2026, 5:00 PM CET
Celon Pharma Company Description
Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.
The company provides drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders.
Celon Pharma S.A. was founded in 2002 and is based in Lomianki, Poland. The company operates as a subsidiary of Glatton Sp.
z o.o.
Celon Pharma S.A.
| Country | Poland |
| Founded | 2002 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 564 |
| CEO | Maciej Wieczorek |
Contact Details
Address: Ogrodowa 2A Lomianki, 05-092 Poland | |
| Phone | 48 227 51 59 33 |
| Website | celonpharma.com |
Stock Details
| Ticker Symbol | CLN |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLCLNPH00015 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Maciej Wieczorek Ph.D. | Chief Executive Officer and President of Management Board |
| Bartosz Szalek | Chief Financial Officer and Member of the Management Board |
| Malgorzata Stokrocka | CDOO and Member of Management Board |